COST-UTILITY AND BUDGET IMPACT ANALYSES OF TUMOR NECROSIS FACTOR INHIBITOR BIOLOGICS AND BIOSIMILARS VERSUS RITUXIMAB IN THAI PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS

被引：0
|
作者：
Leelahavarong, P. [1 ]
Osiri, M. [2 ]
Koolvisoot, A. [3 ]
Prawjaeng, J. [4 ]
Budtarad, N. [1 ]
机构：
[1] Mahidol Univ, Siriraj Hosp, Fac Med, Siriraj Hlth Policy Unit, Bangkok, Thailand
[2] Chulalongkorn Univ, Div Rheumatol, Dept Med, Fac Med, Pathumwan, Thailand
[3] Mahidol Univ, Siriraj Hosp, Fac Med, Div Rheumatol, Bangkok, Thailand
[4] Mahidol Univ, Fac Med, Siriraj Hlth Policy Unit, Siriraj Hosp, Bangkok, Thailand
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE424
引用
收藏
页码：S132 / S133
页数：2
相关论文
共 50 条
  • [41] Changes in Opioid Utilization Following Tumor Necrosis Factor Inhibitor Initiation in Patients with Rheumatoid Arthritis
    Siyeon Park
    Tham T. Le
    Julia F. Slejko
    Ester Villalonga-Olives
    Eberechukwu Onukwugha
    Rheumatology and Therapy, 2019, 6 : 611 - 616
  • [42] CLINICAL AND LABORATORY RESPONSE TO THE USE OF A TUMOR NECROSIS FACTOR INHIBITOR IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS
    Carlos Adarmes, Juan
    Riera, Humberto
    Vera, Mariflor
    Sosa, Angel
    Escobar, Hernan
    Quintero, Maritza
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2018, 24 : S78 - S78
  • [43] Treatment Sequences After Discontinuing a Tumor Necrosis Factor Inhibitor in Patients With Rheumatoid Arthritis: A Comparison of Cycling Versus Swapping Strategies
    Matusevich, Aliza R. Karpes
    Duan, Zhigang
    Zhao, Hui
    Lal, Lincy S.
    Chan, Wenyaw
    Suarez-Almazor, Maria E.
    Giordano, Sharon H.
    Swint, J. Michael
    Lopez-Olivo, Maria A.
    ARTHRITIS CARE & RESEARCH, 2021, 73 (10) : 1461 - 1469
  • [44] Home-based chemotherapy for stage III colon cancer patients in Thailand: Cost-utility and budget impact analyses
    Kulthanachairojana, Nattanichcha
    Chansriwong, Phichai
    Thokanit, Nintita Sripaiboonkij
    Sirilerttrakul, Suwannee
    Wannakansophon, Nopakan
    Taychakhoonavudh, Suthira
    CANCER MEDICINE, 2021, 10 (03): : 1027 - 1033
  • [45] Association between the level of circulating bioactive tumor necrosis factor α and the tumor necrosis factor α gene polymorphism at-308 in patients with rheumatoid arthritis treated with a tumor necrosis factor α inhibitor
    Marotte, Hubert
    Arnaud, Beatrice
    Diasparra, Jennifer
    Zrioual, Saloua
    Miossec, Pierre
    ARTHRITIS AND RHEUMATISM, 2008, 58 (05): : 1258 - 1263
  • [46] Persistence With Conventional Triple Therapy Versus a Tumor Necrosis Factor Inhibitor and Methotrexate in US Veterans With Rheumatoid Arthritis
    Sauer, Brian C.
    Teng, Chia-Chen
    Tang, Derek
    Leng, Jianwei
    Curtis, Jeffrey R.
    Mikuls, Ted R.
    Harrison, David J.
    Cannon, Grant W.
    ARTHRITIS CARE & RESEARCH, 2017, 69 (03) : 313 - 322
  • [47] Cost-utility analysis of certolizumab pegol in combination with methotrexate in patients with moderate-to-severe active rheumatoid arthritis in Greece
    Tzanetakos, C.
    Tzioufas, A.
    Goules, A.
    Kourlaba, G.
    Theodoratou, T.
    Christou, P.
    Maniadakis, N.
    RHEUMATOLOGY INTERNATIONAL, 2017, 37 (09) : 1441 - 1452
  • [48] Cost-utility analysis of certolizumab pegol in combination with methotrexate in patients with moderate-to-severe active rheumatoid arthritis in Greece
    C. Tzanetakos
    A. Tzioufas
    A. Goules
    G. Kourlaba
    T. Theodoratou
    P. Christou
    N. Maniadakis
    Rheumatology International, 2017, 37 : 1441 - 1452
  • [49] Comparative effectiveness and safety of rituximab versus subsequent anti–tumor necrosis factor therapy in patients with rheumatoid arthritis with prior exposure to anti–tumor necrosis factor therapies in the United States Corrona registry
    Leslie R. Harrold
    George W. Reed
    Robert Magner
    Ashwini Shewade
    Ani John
    Jeffrey D. Greenberg
    Joel M. Kremer
    Arthritis Research & Therapy, 17
  • [50] Tumor Necrosis Factor Inhibitor Monotherapy Versus Combination Therapy for the Treatment of Psoriatic Arthritis: Combined Analysis of European Biologics Databases
    Thomas, Matthew L.
    Shaddick, Gavin
    Charlton, Rachel
    Cavill, Charlotte
    Holland, Richard
    Iannone, Florenzo
    Lapadula, Giovanni
    Lopriore, Simona
    Zavada, Jakub
    Uher, Michal
    Pavelka, Karel
    Szczukova, Lenka
    Sidiropoulos, Prodromos
    Flouri, Irini
    Drosos, Alexandros
    Moller, Burkhard
    Nissen, Michael J.
    Mueller, Rudiger B.
    Scherer, Almut
    McHugh, Neil
    Nightingale, Alison
    JOURNAL OF RHEUMATOLOGY, 2021, 48 (01) : 48 - 57
12345